Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhalational vs intravenous sedation in neurocritical patients
2024-512077-27-00Phase 4Authorised
- Sponsor
- Hospital Universitari de Girona Dr. Josep Trueta
- Start
- Mar 2024
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of isoflurane, propofol and midazolam in intracerebral hemorrhage (ICH), traumatic brain injury (TBI), ischemic stroke and 1 more (2 arms), sponsored by Hospital Universitari de Girona Dr. Josep Trueta. Primary endpoint: Sedation variables. Planned start Mar 2024; status: authorised.
02
Drugs
isofluranepropofolmidazolam
03
Conditions
intracerebral hemorrhage (ICH)traumatic brain injury (TBI)ischemic strokebrain hemorrhage (ICH)
Beyond the preview
Go deeper on 2024-512077-27-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512077-27-00.